Prosecution Insights
Last updated: July 17, 2026
Application No. 18/232,748

TRANSPERINEAL PROSTATE BIOPSY DEVICES, SYSTEMS, AND METHODS OF USE

Final Rejection §112
Filed
Aug 10, 2023
Priority
Aug 11, 2022 — provisional 63/371,125 +1 more
Examiner
HOFFA, ANGELA MARIE
Art Unit
3799
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Corbin Clinical Resources LLC
OA Round
2 (Final)
68%
Grant Probability
Favorable
3-4
OA Rounds
1y 2m
Est. Remaining
95%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allowance Rate
373 granted / 552 resolved
-2.4% vs TC avg
Strong +27% interview lift
Without
With
+27.4%
Interview Lift
resolved cases with interview
Typical timeline
4y 1m
Avg Prosecution
28 currently pending
Career history
582
Total Applications
across all art units

Statute-Specific Performance

§101
2.3%
-37.7% vs TC avg
§103
65.1%
+25.1% vs TC avg
§102
3.8%
-36.2% vs TC avg
§112
8.3%
-31.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 552 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of Claims Claims 1-20 are pending. Claim 20 remains withdrawn as being directed to a non-elected invention. Claim Rejections - 35 USC § 112(a) The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1-19 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Claim 1 is directed towards a transperineal biopsy system, including a biopsy guide with guide member and “a fastener extending from the guide member…wherein the fastener includes a first end having a first fastener portion and a second end having a second fastener portion, the first fastener portion configured to releasably couple to the second fastener portion”. In par. 0292, it states “On each outer lateral end of the curvate top surface 4634 is a fastener end 4638 sized and shaped to releasably couple to a corresponding fastener end of a fastener of the biopsy guide (not shown). The corresponding fastener ends of the biopsy guide may be the fastening mechanism 2706 shown in FIGS. 28-30, among others.” Examiner provides annotated Figure 47C as showing the fastener ends of the adaptor and annotated Figure 44B showing the assembled device (adaptor and biopsy guide together) including the first and second fastener portions of the biopsy guide. However, Examiner cannot find support for “the first fastener portion [of the biopsy guide] configured to releasably couple to the second fastener portion [of the biopsy guide]” as required by claim 1. Instead, the first and second fastener portions of the biopsy guide releasably connect to the adaptor. As such, the claim is not supported by the original disclosure and constitutes new matter. PNG media_image1.png 458 726 media_image1.png Greyscale PNG media_image2.png 818 901 media_image2.png Greyscale Claim Rejections - 35 USC § 112(b) The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 7-8 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding Claims 7-8, it is not understood what is meant by “micro-ultrasound probe” or by “micro-ultrasound probe/MRI fusion probe”. The disclosure provides paragraph 00270 and Figures 39A-39E element 3900 as showing the “micro-ultrasound probe” and asserts that “micro-ultrasound/MRI fusion probe” is equivalent to “micro-ultrasound probe”. As such, claim 7 and claim 8 appear to be the same scope and therefore duplicate claims. It is unclear if claims 7 or 8 further limit the scope of the invention from claim 1+6 because it is not understood how a “micro-ultrasound probe” is any different than the “angled ultrasound probe” from claim 1+6. There is no disclosure related to what makes the probe “micro” and one of ordinary skill would not understand this meaning in the context of the disclosure. For example, Figure 39C micro-ultrasound probe 3900 shows the probe is handheld size, thereby contradicting the plain meaning of “micro-ultrasound probe” being an ultrasound probe of micro size. As such, the scope sought by claims 7 and 8 cannot be determined. During examination, the claim terms “micro-ultrasound probe” and “micro-ultrasound/MRI fusion probe” will be given the interpretation of a handheld angled ultrasound probe. Should Claim 7 be “handheld” ultrasound probe instead? Should Claim 8 be canceled as being a duplicate? Claim Rejections - 35 USC § 112(d) The following is a quotation of 35 U.S.C. 112(d): (d) REFERENCE IN DEPENDENT FORMS.—Subject to subsection (e), a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. The following is a quotation of pre-AIA 35 U.S.C. 112, fourth paragraph: Subject to the following paragraph [i.e., the fifth paragraph of pre-AIA 35 U.S.C. 112], a claim in dependent form shall contain a reference to a claim previously set forth and then specify a further limitation of the subject matter claimed. A claim in dependent form shall be construed to incorporate by reference all the limitations of the claim to which it refers. Claims 7-8 are rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. For the reasons above in the rejection of claims 7-8 under USC 112(b), the claims do not limit the requirements of their parent claim 1+6 and therefore are not proper dependent claims. As discussed above, being “micro-ultrasound probe” and “micro-ultrasound probe/MRI fusion probe” do not appear to narrow the scope of “angled ultrasound probe”. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Response to Arguments Applicant’s arguments, see remarks, filed April 16, 2026, with respect to the rejection(s) of claim(s) 1-19 in view of the prior art have been fully considered and are persuasive. Therefore, the rejection has been withdrawn. However, upon further consideration, a new ground(s) of rejection is made in view of new matter introduced into the claims. The rejection under USC 112(b) and 112(d) are also maintained. Changing the dependency of claims 7-8 to depend on claim 6 did not resolve the issue for the reasons in the rejection above. Should Claim 7 be “handheld” ultrasound probe instead? Should Claim 8 be canceled as being a duplicate? Regarding the prior art, Applicant argues Allaway (US 20160022309) does not teach the amended limitation “the first fastener portion configured to releasably couple to the second fastener portion”. Examiner notes the fastener is part of the biopsy guide and extends from the guide member, and clearly in Allaway the first fastener portion and the second fastener portion do not releasably couple from each other. Rather, in the interpretation used by the examiner in the previous office action for the fastener portions, they are an integrated piece (shown annotated below for reference). As such, Allaway does not teach the amended claim 1. Examiner notes that the adaptor of Allaway is different than the adaptor disclosed in the instant application (e.g. Figure 47C). However, the claims do not yet distinguish between the structure of the adaptors. PNG media_image3.png 562 375 media_image3.png Greyscale Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ANGELA MARIE HOFFA whose telephone number is (571)270-7408. The examiner can normally be reached Monday - Friday 9:30 am - 6:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Keith Raymond can be reached at (571)270-1790. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. ANGELA M. HOFFA Primary Examiner Art Unit 3799 /Angela M Hoffa/Primary Examiner, Art Unit 3799
Read full office action

Prosecution Timeline

Aug 10, 2023
Application Filed
Jan 16, 2026
Non-Final Rejection mailed — §112
Apr 16, 2026
Response Filed
Jun 29, 2026
Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678238
REAL-TIME INSTRUMENT POSITION IDENTIFICATION AND TRACKING
3y 5m to grant Granted Jul 14, 2026
Patent 12678359
INTELLIGENT ANIMAL OPERATION TABLE
2y 2m to grant Granted Jul 14, 2026
Patent 12642597
Technique For Determining A Need For A Re-Registration Of A Patient Tracker
3y 4m to grant Granted Jun 02, 2026
Patent 12636120
SYSTEMS, METHODS, AND DEVICES FOR DETERMINING AN OBJECT POSE
2y 6m to grant Granted May 26, 2026
Patent 12622767
TISSUE MARKERS
7y 8m to grant Granted May 12, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
68%
Grant Probability
95%
With Interview (+27.4%)
4y 1m (~1y 2m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 552 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month